Cargando…

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria

INTRODUCTION: The aMAP score is a prediction model for hepatocellular carcinoma (HCC) risk in chronic hepatitis patients. This study was conducted to elucidate the utility of this model for predicting initial recurrence of HCC in patients within the Milan criteria after undergoing curative treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohama, Hideko, Hiraoka, Atsushi, Tada, Fujimasa, Kato, Kanako, Fukunishi, Yoshiko, Yanagihara, Emi, Kato, Masaya, Saneto, Hironobu, Izumoto, Hirofumi, Ueki, Hidetaro, Yoshino, Takeaki, Kitahata, Shogo, Kawamura, Tomoe, Kuroda, Taira, Suga, Yoshifumi, Miyata, Hideki, Hirooka, Masashi, Abe, Masanori, Matsuura, Bunzo, Ninomiya, Tomoyuki, Hiasa, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614485/ https://www.ncbi.nlm.nih.gov/pubmed/37459848 http://dx.doi.org/10.1159/000530987

Ejemplares similares

Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment
por: Ohama, Hideko, et al.
Publicado: (2022)

Simple method for predicting muscle volume loss using geriatric nutritional risk index in hepatocellular carcinoma patients
por: Hiraoka, Atsushi, et al.
Publicado: (2023)

Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma
por: Ohama, Hideko, et al.
Publicado: (2022)

Easy surveillance of muscle volume decline in chronic liver disease patients using finger‐circle (yubi‐wakka) test
por: Hiraoka, Atsushi, et al.
Publicado: (2019)

Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker
por: Hiraoka, Atsushi, et al.
Publicado: (2021)

Factors Related to Sleeping Disorder Due to Pruritus in Patients with Chronic Liver Disease
por: Hiraoka, Atsushi, et al.
Publicado: (2021)

Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
por: Nakamura, Yoshiko, et al.
Publicado: (2023)

SARC‐F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease
por: Hiraoka, Atsushi, et al.
Publicado: (2020)

B cell activating factor in obesity is regulated by oxidative stress in adipocytes
por: Tada, Fujimasa, et al.
Publicado: (2013)

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality
por: Hiraoka, Atsushi, et al.
Publicado: (2023)

AMAP assessment 2015: human health in the Arctic
por: Odland, Jon Øyvind, et al.
Publicado: (2016)

Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
por: Ochi, Hironori, et al.
Publicado: (2020)

Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation
por: Hiraoka, Atsushi, et al.
Publicado: (2015)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
por: Li, Jiao, et al.
Publicado: (2021)

Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
por: Yasuoka, Hidetaka, et al.
Publicado: (2020)

Association between Administration of Antithrombotics and Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases
por: Asai, Akira, et al.
Publicado: (2021)

Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
por: Tada, Toshifumi, et al.
Publicado: (2022)

New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study
por: Tada, Toshifumi, et al.
Publicado: (2022)

AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
por: Watanabe, Takao, et al.
Publicado: (2021)

GWAS in a Box: Statistical and Visual Analytics of Structured Associations via GenAMap
por: Xing, Eric P., et al.
Publicado: (2014)

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Horikawa, Mei, et al.
Publicado: (2021)

The role of the Arctic Monitoring and Assessment Programme (AMAP) in reducing pollution of the Arctic and around the globe
por: Reiersen, Lars-Otto, et al.
Publicado: (2023)

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
por: Watanabe, Takao, et al.
Publicado: (2023)

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
por: TADA, FUJIMASA, et al.
Publicado: (2012)

Effects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic Mice
por: Kawamura, Tomoe, et al.
Publicado: (2019)

aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data
por: Niedworok, Christian J., et al.
Publicado: (2016)

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
por: Johnson, Philip J., et al.
Publicado: (2022)

Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis
por: Kitahata, Shogo, et al.
Publicado: (2021)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Pablo Milanes
Publicado: (1985)

Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
por: Tanaka, Kazunari, et al.
Publicado: (2023)

AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions
por: Tien, Dat Nguyen, et al.
Publicado: (2014)

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma
por: Hiraoka, Atsushi, et al.
Publicado: (2020)

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting
por: Hiraoka, Atsushi, et al.
Publicado: (2020)

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib
por: Tada, Toshifumi, et al.
Publicado: (2021)

Protein Kinase R Modulates c-Fos and c-Jun Signaling to Promote Proliferation of Hepatocellular Carcinoma with Hepatitis C Virus Infection
por: Watanabe, Takao, et al.
Publicado: (2013)

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
por: Nakamura, Yoshiko, et al.
Publicado: (2019)

The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis(†)
por: Sabe, Hisataka, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6vabvrqjl2v61aupde3pqomk37